These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 14783835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A new orally effective longacting ganglion-blocking agent for hypertension (189c56).
    LOCKET S.
    Br Med J; 1958 Jul 12; 2(5088):74-8. PubMed ID: 13546651
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [VASOMOTOR EFFECTS OF GANGLIOPLEGIC AGENTS].
    ZAMBONI P.
    Arch Ital Sci Farmacol; 1963 Apr 12; 13():97-117. PubMed ID: 14245141
    [No Abstract] [Full Text] [Related]

  • 6. [Use of neuroplegic and ganglion-blocking drugs in the treatment of craniocerebral injuries].
    UGLOV FG, LUCHKO GD.
    Vestn Khir Im I I Grek; 1962 Nov 12; 89():63-9. PubMed ID: 13995220
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Ganglionic-blocking agents. 9].
    Jannasch R.
    Pharm Prax; 1967 Nov 12; 7():198-204. PubMed ID: 4389435
    [No Abstract] [Full Text] [Related]

  • 9. Some preliminary observations on the neuromuscular and ganglionic blocking action in man of bis-trimethylammonium decane and petane dirodide.
    GROB D, HARVEY AM, HOLADAY DA.
    Bull Johns Hopkins Hosp; 1949 Mar 12; 84(3):279-82. PubMed ID: 18113847
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of acute and subacute pulmonary hypertension with ganglionic-blocking agents].
    KLEINERMAN L, GOLDENBERG V, BUSU I.
    Med Interna (Bucur); 1959 May 12; 11():739-43. PubMed ID: 13853412
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hexamethonium (C6) in the management of causalgia.
    ROSE JC, WEMPLE JN.
    U S Armed Forces Med J; 1951 Jun 12; 2(6):937-42. PubMed ID: 14846249
    [No Abstract] [Full Text] [Related]

  • 14. [Ganglionic-blockading action of bis-ammonium compounds].
    Skok VI, Selianko AA, Derkach VA, Gmiro VE, Lukomskaia NIa.
    Neirofiziologiia; 1984 Jun 12; 16(1):54-61. PubMed ID: 6144051
    [Abstract] [Full Text] [Related]

  • 15. [Clinical experiences with ganglion blocking agent penthonium].
    BLOCK A.
    Medizinische; 1956 Aug 25; 7(33-34):1136-9. PubMed ID: 13358468
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of a ganglion-blocking agent, hexamethonium bitartrate on the induction of experimental erythema in guinea pigs and man].
    PANCONESI E.
    Rass Dermatol Sifilogr; 1955 Aug 25; 8(3):149-74. PubMed ID: 13290051
    [No Abstract] [Full Text] [Related]

  • 18. Decamethonium and hexamethonium; a clinical and experimental study.
    HUNTER AR.
    Br J Anaesth; 1950 Oct 25; 22(4):218-34. PubMed ID: 14777848
    [No Abstract] [Full Text] [Related]

  • 19. [A comparative study of the effect of various ganglionic blocking substances on autonomic disorders in closed cranio-cerebral trauma].
    Ul'ianychev NV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Sep 25; 69(9):1327-33. PubMed ID: 4391455
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.